(R)-Methyl 2-amino-6-((tert-butoxycarbonyl)amino)hexanoate

97%

Reagent Code: #228669
fingerprint
CAS Number 63328-49-4

science Other reagents with same CAS 63328-49-4

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 260.33 g/mol
Formula C₁₂H₂₄N₂O₄
badge Registry Numbers
MDL Number MFCD02094344
inventory_2 Storage & Handling
Storage -20°C, light-proof, inert gas

description Product Description

Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other bioactive molecules. Its protected amine and carboxylate functional groups allow for selective peptide coupling, making it valuable in solid-phase and solution-phase peptide synthesis. Commonly employed in the preparation of enzyme inhibitors targeting diseases such as hypertension, viral infections (e.g., HIV), and cancer. The stereochemistry at the alpha position ensures high enantioselectivity in final active compounds, enhancing drug efficacy and reducing side effects.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 100mg
10-20 days ฿6,050.00
inventory 1g
10-20 days ฿28,060.00
(R)-Methyl 2-amino-6-((tert-butoxycarbonyl)amino)hexanoate
No image available

Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other bioactive molecules. Its protected amine and carboxylate functional groups allow for selective peptide coupling, making it valuable in solid-phase and solution-phase peptide synthesis. Commonly employed in the preparation of enzyme inhibitors targeting diseases such as hypertension, viral infections (e.g., HIV), and cancer. The stereochemistry at the alpha position ensures

Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other bioactive molecules. Its protected amine and carboxylate functional groups allow for selective peptide coupling, making it valuable in solid-phase and solution-phase peptide synthesis. Commonly employed in the preparation of enzyme inhibitors targeting diseases such as hypertension, viral infections (e.g., HIV), and cancer. The stereochemistry at the alpha position ensures high enantioselectivity in final active compounds, enhancing drug efficacy and reducing side effects.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...